Company number 10551358
Status Active
Incorporation Date 6 January 2017
Company Type Private Limited Company
Address BUILDING 3 GLORY PARK AVENUE, WOOBURN GREEN, HIGH WYCOMBE, BUCKINGHAMSHIRE, UNITED KINGDOM, HP10 0DF
Home Country United Kingdom
Nature of Business 64209 - Activities of other holding companies n.e.c.
Phone, email, etc
Since the company registration nine events have happened. The last three records are Resolutions
RES10 ‐
Resolution of allotment of securities
; Appointment of Mr David Isaacs as a director on 9 March 2017; Statement of capital following an allotment of shares on 1 February 2017
USD 37.00
. The most likely internet sites of TAKEDA USF LTD are www.takedausf.co.uk, and www.takeda-usf.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and one months. The distance to to Taplow Rail Station is 5.1 miles; to Burnham (Berks) Rail Station is 5.4 miles; to Maidenhead Rail Station is 5.7 miles; to Slough Rail Station is 7.1 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Takeda Usf Ltd is a Private Limited Company.
The company registration number is 10551358. Takeda Usf Ltd has been working since 06 January 2017.
The present status of the company is Active. The registered address of Takeda Usf Ltd is Building 3 Glory Park Avenue Wooburn Green High Wycombe Buckinghamshire United Kingdom Hp10 0df. . ISAACS, David is a Director of the company. KEHOE, James is a Director of the company. KJAERGAARD, Nils is a Director of the company. SAROUKOS, Costa is a Director of the company. The company operates in "Activities of other holding companies n.e.c.".
Current Directors
Persons With Significant Control
Takeda Pharmaceutical Company Limited
Notified on: 6 January 2017
Nature of control: Ownership of shares – 75% or more
TAKEDA USF LTD Events
14 Mar 2017
Resolutions
-
RES10 ‐
Resolution of allotment of securities
10 Mar 2017
Appointment of Mr David Isaacs as a director on 9 March 2017
16 Feb 2017
Statement of capital following an allotment of shares on 1 February 2017
15 Feb 2017
Statement of capital following an allotment of shares on 1 February 2017
08 Feb 2017
Appointment of Costa Saroukos as a director on 2 February 2017
13 Jan 2017
Register(s) moved to registered inspection location First Floor 100 Victoria Embankment London EC4Y 0DH
13 Jan 2017
Register inspection address has been changed to First Floor 100 Victoria Embankment London EC4Y 0DH
06 Jan 2017
Current accounting period extended from 31 January 2018 to 31 March 2018
06 Jan 2017
Incorporation
-
MODEL ARTICLES ‐
Model articles adopted (Amended Provisions)
Statement of capital on 2017-01-06